These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35746726)

  • 1. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants.
    Ghimire D; Han Y; Lu M
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy.
    Yang Z; Han Y; Ding S; Shi W; Zhou T; Finzi A; Kwong PD; Mothes W; Lu M
    mBio; 2021 Feb; 13(1):e0322721. PubMed ID: 35164561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-COV-2 Variants: Differences and Potential of Immune Evasion.
    Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL
    Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern.
    Shajahan A; Pepi LE; Kumar B; Murray NB; Azadi P
    Sci Rep; 2023 Jun; 13(1):10053. PubMed ID: 37344512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress in spike mutations of SARS-CoV-2 variants and vaccine development.
    He X; He C; Hong W; Yang J; Wei X
    Med Res Rev; 2023 Jul; 43(4):932-971. PubMed ID: 36929527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.
    Qing E; Gallagher T
    mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.
    Li Y; Shen Y; Zhang Y; Yan R
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera.
    Rathnasinghe R; Jangra S; Ye C; Cupic A; Singh G; Martínez-Romero C; Mulder LCF; Kehrer T; Yildiz S; Choi A; Yeung ST; Mena I; Gillespie V; De Vrieze J; Aslam S; Stadlbauer D; Meekins DA; McDowell CD; Balaraman V; Corley MJ; Richt JA; De Geest BG; Miorin L; ; Krammer F; Martinez-Sobrido L; Simon V; García-Sastre A; Schotsaert M
    Nat Commun; 2022 Jul; 13(1):3921. PubMed ID: 35798721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.
    Aksenova AY; Likhachev IV; Grishin SY; Galzitskaya OV
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein.
    Yao Z; Zhang L; Duan Y; Tang X; Lu J
    J Infect; 2024 Mar; 88(3):106121. PubMed ID: 38367704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity.
    Beitari S; Duque D; Bavananthasivam J; Hewitt M; Sandhu JK; Hadžisejdić I; Tran A
    Virol J; 2023 Jul; 20(1):167. PubMed ID: 37507719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
    Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
    Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
    Front Immunol; 2022; 13():801522. PubMed ID: 35222380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
    Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
    Front Immunol; 2022; 13():954435. PubMed ID: 36569921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.